Wednesday, October 6, 2021

Gene therapy developer gets chance at a comeback with Pfizer deal | BioPharma Dive

The big drugmaker has clinical-stage gene therapy programs in Duchenne muscular dystrophy and hemophilia. However, some mutation-driven neurologic diseases have ...
https://www.google.com/url?rct=j&sa=t&url=https://www.biopharmadive.com/news/voyager-pfizer-gene-therapy-deal-aav-capsid/607766/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGuV6HyhxXlVm-_T8unKFXqnNAYcA

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...